Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Inventory: 2024-2025

Historic Inventory for Autolus Therapeutics (AUTL) over the last 1 years, with Sep 2025 value amounting to $27.7 million.

  • Autolus Therapeutics' Inventory was N/A to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Autolus Therapeutics' Inventory stood at $27.7 million, which was up 15.79% from $23.9 million recorded in Q2 2025.
  • Autolus Therapeutics' Inventory's 5-year high stood at $27.7 million during Q3 2025, with a 5-year trough of $4.1 million in Q4 2024.
  • Moreover, its 2-year median value for Inventory was $19.3 million (2025), whereas its average is $17.6 million.